Recall: D-0596-2018

Class I - Dangerous

Class IClassification
2018-02-07Initiated
TerminatedStatus
Pfizer Inc.Firm

Product

Hydromorphone, Hydrochloride, Injection, USP CII, 10 mg/mL, Rx Only, 1 mL Single-dose Vial, High Potency Formulation. Mfd For: Teva Parenteral Medicines, Inc., Irvine, CA 92618. NDC: 0703-0110-01

Reason

Non-Sterility: Confirmed customer complaints of glass product container vials that may be empty or cracked.

Distribution

Nationwide in the USA

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.